Zobrazeno 1 - 4
of 4
pro vyhledávání: '"B W, Caprathe"'
Autor:
J L, Wright, B W, Caprathe, D M, Downing, S A, Glase, T G, Heffner, J C, Jaen, S J, Johnson, S R, Kesten, R G, MacKenzie, L T, Meltzer
Publikováno v:
Journal of medicinal chemistry. 37(21)
A novel dopamine (DA) autoreceptor agonist, 1,2,3,6-tetrahydro-4-phenyl-1- [(3-phenyl-3-cyclohexen-1-yl)methyl]pyridine (14), was identified. The structure-activity relationships surrounding this compound were studied by synthesis of analogues and ev
Autor:
L T, Meltzer, B W, Caprathe, C L, Christoffersen, A E, Corbin, J C, Jaen, F W, Ninteman, T A, Pugsley, K A, Serpa, Y H, Shih, S Z, Whetzel
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 266(3)
(+/-)-PD 128483, ((+/-)-4,5,5a,6,7,8-hexahydro-6-methylthiazolo[4,5-f]-quinolin+ ++-2-amine, maleate (1:1)), is a racemic compound that is a p.o. active dopamine (DA) partial agonist that has DA autoreceptor agonist effects and displays antipsychotic
Publikováno v:
Pharmaceutical research. 8(8)
Reduced haloperidol (RHAL) is the best known metabolite of haloperidol (HAL), having been identified in humans, rats, and guinea pigs. Since RHAL contains an asymmetric center, it can exist in two possible enantiomeric forms. However, the enantiomeri
Autor:
N. A. Lebel, B. W. Caprathe
Publikováno v:
Chemischer Informationsdienst. 17